Skip to main content
SpringerLink
Log in

Pharmaceutical Care Versus Traditional Drug Treatment

Is There a Difference?

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nelson C, McLemore T. National Ambulatory Medical Care Survey: 1975-81 and 1985. Vit Health Stat 1988; Series 13: 1-50

  2. Schappert SM. National Ambulatory Medical Care Survey: 1989 summary. Vital Health Stat 1992; 1-80

  3. Parish PA. What future for pharmacy practice?. Pharmaceutical J 1985; 234: 209–11

    Google Scholar 

  4. Brodie DC, Parish PA, Poston JW. Societal needs for drugs and drug related services. Am J Pharm Ed 1980; 44: 276–8

    CAS  Google Scholar 

  5. Hepler CD. Unresolved issues in the future of pharmacy. Am J Hosp Pharm 1988; 45: 1071–81

    PubMed  CAS  Google Scholar 

  6. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–43

    PubMed  CAS  Google Scholar 

  7. Burnum JF. Preventability of adverse drug reactions. Ann Intern Med 1976; 85: 80–1

    PubMed  CAS  Google Scholar 

  8. McKenney JM, Harrison WL. Drug-related hospital admissions. Am J Hosp Pharm 1976; 33: 792–5

    PubMed  CAS  Google Scholar 

  9. Stewart RB, Springer P, Adams J. Drug related hospitalizations to an inpatient psychiatry unit. Am J Psychiat 1980; 137: 1093–95

    PubMed  CAS  Google Scholar 

  10. Hindi Alexander MC, Middleton Jr E. Asthma deaths: are they preventable?. N Engl Reg Allergy Proc 1986; 7: 462–6

    Article  PubMed  CAS  Google Scholar 

  11. Lakshmanan MC, Hershey CO, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med 1986; 146: 1931–4

    Article  PubMed  CAS  Google Scholar 

  12. Ives TJ, Bentz EJ, Gwyther RE. Drug-related admissions to a family medicine service. Arch Intern Med 1987; 147: 1117–20

    Article  PubMed  CAS  Google Scholar 

  13. Fletcher HJ, Ibrahim SA, Speight N. Survey of asthma deaths in the Northern region, 1970–85. Arch Dis Child 1990; 65: 163–7

    Article  PubMed  CAS  Google Scholar 

  14. Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83–90

    Article  PubMed  CAS  Google Scholar 

  15. Hallas J, Haghfelt T, Gram LF, et al. Drug related admissions to a cardiology department: frequency and avoidability. J Intern Med 1990; 228: 379–84

    Article  PubMed  CAS  Google Scholar 

  16. Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Med Care 1991; 29: 989–1003

    Article  PubMed  CAS  Google Scholar 

  17. Hallas J, Jensen KB, Grodum E, et al. Drug-related admissions to a department of medical gastroenterology: the role of self-medicated and prescribed drugs. Scand J Gastroenterol 1991; 26: 174–80

    Article  PubMed  CAS  Google Scholar 

  18. Schiff GD, Hegde HK, LaCloche L, et al. Inpatient theophylline toxicity: preventable factors [see comments]. Ann Intern Med 1991; 114: 748–53

    PubMed  CAS  Google Scholar 

  19. Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61–8

    Article  PubMed  CAS  Google Scholar 

  20. Hallas J, Davidsen O, Grodum E, et al. Drug-related illness as a cause of admission to a department of respiratory medicine. Respiration 1992; 59: 30–4

    Article  PubMed  CAS  Google Scholar 

  21. Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294–300

    Article  PubMed  CAS  Google Scholar 

  22. Lip GY, Brodie MJ. Sudden death in epilepsy: an avoidable outcome?. J R Soc Med 1992; 85: 609–11

    PubMed  CAS  Google Scholar 

  23. Nikolaus T, Specht Leible N, Kruse W, et al. [The early rehospitalization of elderly patients: causes and prevention] Frühe Rehospitalisierung hochbetagter Patienten: Ursachen und Prävention. Dtsch Med Wochenschr 1992; 117: 403–7

    Article  PubMed  CAS  Google Scholar 

  24. Spreux A, Chichmanian RM, Castot A. [Economic impact of adverse drug effects: some reflections] Impact economique des effets indesirables des medicaments: quelques reflexions. Therapie 1992; 47: 385–8

    PubMed  CAS  Google Scholar 

  25. Ryan CA, Dowling G. Drowning deaths in people with epilepsy. Can Med Assoc J 1993; 148: 781–4

    CAS  Google Scholar 

  26. Wagdi P, Vuilliomenet A, Kaufmann U, et al. [Inadequate treatment compliance, patient information and drug prescription as causes for emergency hospitalization of patients with chronic heart failure] Ungenugende Behandlungsdisziplin, Patienteninformation und Medikamentenverschreibung als Ursachen für die Notfallhospitalisation bei chronisch herzinsuffizienten Patienten. Schweiz Med Wochenschr 1993; 123: 108–12

    PubMed  CAS  Google Scholar 

  27. Southwick K. A prescription for trouble: drugs to counteract drugs. Health Week 1988; 2 (16) August 8: 1, 12

    Google Scholar 

  28. Hepler CD. New directions in education and practice: pharmaceutical care. In: Osterweis M, Robin ER, editors. Health professions educators confront a new era. Proceedings of the 1st Congress of Health Professions Educators. Washington D.C.: Association of Academic Health Centers, 1993: 61–79

    Google Scholar 

  29. Trunet P, LeGall JR, Lhoste F, et al. The role of iatrogenic disease in admissions to intensive care. JAMA 1980; 244: 2617–20

    Article  PubMed  CAS  Google Scholar 

  30. Trunet P, Borda IT, Rouget A-V, et al. The role of drug-induced illness in admissions to an intensive care unit. Intensive Care Med 1986; 12: 43–6

    Article  PubMed  CAS  Google Scholar 

  31. Eisenberg JM, Koffer H, Glick HA, et al. What is the cost of nephrotoxicity associated with aminoglycosides?. Ann Intern Med 1987; 107: 900–9

    PubMed  CAS  Google Scholar 

  32. Dubois RW, Brook RH. Preventable deaths: who, how often, and why?. Ann Intern Med 1988; 109: 582–9

    PubMed  CAS  Google Scholar 

  33. Noyes M, Polk RE. Norfloxacin and absorption of magnesiumaluminum. Ann Intern Med 1988; 109: 168–9

    PubMed  CAS  Google Scholar 

  34. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. N Engl J Med 1991; 324: 370–6

    Article  PubMed  CAS  Google Scholar 

  35. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377–84

    Article  PubMed  CAS  Google Scholar 

  36. Brennan TA, Hebert LE, Laird NM, et al. Hospital characteristics associated with adverse events and substandard care. JAMA 1991; 265: 3265–9

    Article  PubMed  CAS  Google Scholar 

  37. Bedell SE, Deitz DC, Leeman D, et al. Incidence and characteristics of preventable iatrogenic cardiac arrests. JAMA 1991; 265: 2815–20

    Article  PubMed  CAS  Google Scholar 

  38. Bigby J, Dunn J, Goldman L, et al. Assessing the preventability of emergency hospital admissions: a method for evaluating the quality of medical care in a primary care facility. Am J Med 1987; 83: 1031–6

    Article  PubMed  CAS  Google Scholar 

  39. Barr DP. Hazards of modern diagnosis and therapy — the price we pay. JAMA 1955; 159: 1452–6

    Article  CAS  Google Scholar 

  40. Moser RH. Diseases of Medical Progress. N Engl J Med 1956; 255: 606–14

    Article  PubMed  CAS  Google Scholar 

  41. Melmon KL. Preventable drug reactions-causes and cures. N Engl J Med 1971; 284: 1361–8

    Article  PubMed  CAS  Google Scholar 

  42. Porter J, Jick H. Drug-related deaths among medical inpatients. JAMA 1977; 237: 879–81

    Article  PubMed  CAS  Google Scholar 

  43. Hallas J, Worm J, Beck Nielsen J, et al. Drug related events and drug utilization in patients admitted to a geriatric hospital department. Dan Med Bull 1991; 38: 417–20

    PubMed  CAS  Google Scholar 

  44. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of the experimental literature. Millbank Q 1989; 67: 268–317

    Article  CAS  Google Scholar 

  45. Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990; 38: 542–52

    PubMed  CAS  Google Scholar 

  46. Soumerai SB, Avorn J. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. Millbank Q 1984; 62: 447–74

    CAS  Google Scholar 

  47. Sloan FA, Gordon GS, Cocks DL. Hospital drug formularies and use of hospital services. Med Care 1993; 31: 851–67

    Article  PubMed  CAS  Google Scholar 

  48. Clapham CE, Hepler CD, Reinders TP, et al. Economic consequences of two drug-use control systems in a teaching hospital. Am J Hosp Pharm 1988; 45: 2329–40

    PubMed  CAS  Google Scholar 

  49. Kidder SW. Cost-benefit of pharmacist-conducted drug-regimen reviews. Cons Pharm 1987; 2: 394–8

    Google Scholar 

  50. Thompson JF, McGhan WF, Ruffalo RL, et al. Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. J Am Geriatr Soc 1984; 32: 154–9

    PubMed  CAS  Google Scholar 

  51. Hawkins DW, Fiedler FP, Douglas HL, et al. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979; 36: 1321–25

    PubMed  CAS  Google Scholar 

  52. Sczupak CA, Conrad WF. Relationship between patient oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm 1977; 34: 1238–42

    PubMed  CAS  Google Scholar 

  53. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost justification of a clinical pharmacist managed anticoagulation clinic. Ann Pharmacother 1985; 19: 575–80

    CAS  Google Scholar 

  54. McKenney JM, Slining JM, Henderson HR, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1979; 48: 1104–11

    Article  Google Scholar 

  55. Chrischilles EA, Helling DK, Aschoff CR. Effect of clinical pharmacy services on the quality of family practice physician prescribing and medication costs. Ann Pharmacother 1989; 23: 417–21

    CAS  Google Scholar 

  56. Hepler CD. Issues and outcomes in pharmaceutical program evaluation. J Soc Admin Pharm 1991; 8: 141–9

    Google Scholar 

  57. Lobas NH, Lepinski PW, Abramowitz PW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory care clinic. Am J Hosp Pharm 1992; 49: 1681–8

    PubMed  CAS  Google Scholar 

  58. Bjornson DC, Hiner WO, Potyk RP, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 1993; 50: 1875–84

    PubMed  CAS  Google Scholar 

  59. Borgsdorf LR, Knapp KK, Miano JS. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm 1994; 51: 772–7

    PubMed  CAS  Google Scholar 

  60. Black BL. Resource book on progressive pharmaceutical services. Bethesda (MD): American Society of Hospital Pharmacists, 1986

  61. Hatoum HT, Catizone C, Hutchinson RA, et al. An eleven-year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Ann Pharmacother 1986; 20: 33–48

    CAS  Google Scholar 

  62. Witte KW, Hatoum HT, Hoon TJ. Contribution of clinical pharmacists to cefazolin utilization. Hosp Formulary 1987; 22: 737–41

    CAS  Google Scholar 

  63. Hatoum HT, Hutchinson RA, Witte KW, et al. Evaluation of the contributions of clinical pharmacists: inpatient care and cost reduction. Ann Pharmacother 1988; 22: 252–9

    CAS  Google Scholar 

  64. Hatoum HT, Witte KW, Hutchinson RA. Patient care contributors of clinical pharmacists in four ambulatory care clinics. Hosp Pharm 1992; 27: 203–9

    PubMed  CAS  Google Scholar 

  65. Hatoum HT, Akhras K. 1993 Bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother 1993; 27: 1106–19

    PubMed  CAS  Google Scholar 

  66. Hepler CD. Clozapine and the outmoded drug use process. Am Pharmacy 1990; NS30: 39-40

    Google Scholar 

  67. Weed LL. New premises and new tools for medical care and medical education. Meth Inform Med 1989; 28: 207–14

    PubMed  CAS  Google Scholar 

  68. Ray WA, Griffin MR, Schaffer W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363–9

    Article  PubMed  CAS  Google Scholar 

  69. Max MB. Improving outcomes of analgesic treatment: is education enough?. Ann Intern Med 1990; 113: 885–9

    PubMed  CAS  Google Scholar 

  70. Strand LM, Cipolle RJ, Morley PC, et al. Levels of pharmaceutical care: a needs-based approach. Am J Hosp Pharm 1991; 48: 547–0

    PubMed  CAS  Google Scholar 

  71. Strand LM, Cipolle RJ, Morley PC. Pharmaceutical care: an introduction. Kalamazoo (MI): Upjohn Company, 1992

    Google Scholar 

  72. Strand LM, Cipolle RJ, Morley PC. Drug related problems: their structure and function. Ann Pharmacother 1990; 24: 1093–7

    CAS  Google Scholar 

  73. Strand LM, Cipolle RJ, Morley PC. Documenting the clinical pharmacist’s activities: back to basics. Ann Pharmacother 1988; 22: 63–6

    CAS  Google Scholar 

  74. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501–6

    Article  PubMed  CAS  Google Scholar 

  75. Wilcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994; 272: 292–6

    Article  Google Scholar 

  76. Santiago JV. Lessons from the Diabetes Control and Complications Trial. Diabetes 1993; 42: 1549–54

    PubMed  CAS  Google Scholar 

  77. Hepler CD. Pharmacy as a clinical profession. Am J Hosp Pharm 1985; 42: 1298–306

    PubMed  CAS  Google Scholar 

  78. Brown P. Are pharmacists necessary?. Scrip 1994; No. 24 (May): 3-4

  79. Michel NE. Projects study pharmaceutical care outcomes in ambulatory patients. Am J Hosp Pharm 1993; 50: 1527–35

    Google Scholar 

  80. Angaran DM. Quality assurance to quality improvement: measuring and monitoring pharmaceutical care. Am J Hosp Pharm 1991; 48: 1901–7

    PubMed  CAS  Google Scholar 

  81. Angaran DM. Selecting, developing, and evaluating indicators. Am J Hosp Pharm 1991; 48: 1931–7

    PubMed  CAS  Google Scholar 

  82. Nadzam DM. Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations. Am J Hosp Pharm 1991; 48: 1925–30

    PubMed  CAS  Google Scholar 

  83. Cipolle RJ. Drugs don’t have doses — people have doses. Ann Pharmacother 1986; 20: 881–2

    CAS  Google Scholar 

  84. Wulff HR. Rational diagnosis and treatment. J Med Phil 1986; 11: 123–34

    Article  CAS  Google Scholar 

  85. Thomasma DC. Philosophical reflections on a rational treatment plan. J Med Phil 1986; 11: 157–65

    Article  CAS  Google Scholar 

  86. Gatens-Robinson E. Clinical judgement and the rationality of the human sciences. J Med Phil 1986; 11: 167–78

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy Health Care Administration and DuBow Family Center for Research in Pharmaceutical Care, College of Pharmacy, J. Hillis Miller Health Center, University of Florida, P.O. Box 100496, Gainesville, Florida, 32610-0496, USA

    Charles D. Hepler

  2. DuBow Family Center for Research in Pharmaceutical Care, College of Pharmacy, University of Florida, Gainesville, Florida, USA

    Timothy-John Grainger-Rousseau

Authors
  1. Charles D. Hepler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy-John Grainger-Rousseau
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hepler, C.D., Grainger-Rousseau, TJ. Pharmaceutical Care Versus Traditional Drug Treatment. Drugs 49, 1–10 (1995). https://doi.org/10.2165/00003495-199549010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199549010-00001

Keywords

Search

Navigation